Yongbao Wei

MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer

Yongbao Wei, Jinrui Yang, Lu Yi et al. · Scientific Reports · 2014 · 109 citations · Full text

Medicine, Molecular Biology, Oncology +17

Micro-ribonucleic acid 29b inhibits cell proliferation and invasion and enhances cell apoptosis and chemotherapy effects of cisplatin via targeting of DNMT3b and AKT3 in prostate cancer

Jinrui Yang, Bin Yan, Qiong Guo et al. · OncoTargets and Therapy · 2015 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Disitamab vedotin in combination with immune checkpoint inhibitors for locally and locally advanced bladder urothelial carcinoma: a two-center’s real-world study

Yongbao Wei, Ruochen Zhang, Chenbo Yu et al. · Frontiers in Pharmacology · 2023 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

MiR-223-3p targets FOXO3a to inhibit radiosensitivity in prostate cancer by activating glycolysis

Ke-qin Zhou, Yongbao Wei, Xurui Li et al. · Life Sciences · 2021 · 29 citations

Medicine, Cancer Biology, Oncology +14

Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial

Yu Zhang, Zhiyi Lin, Tao Li et al. · Scientific Reports · 2022 · 28 citations · Full text

Medicine, Nuclear Medicine, Radiology +17